Altoida

About:

Altoida is creating a new gold standard in brain health with Precision Neurology.

Twitter/X: altoida

Top Investors: Venture Kick, VI Partners, Alzheimer's Drug Discovery Foundation, b2venture, M Ventures

Description:

Altoida is creating a new gold standard in brain health with Precision Neurology. We're radically transforming the method for measuring brain function and diagnosing neurological disease, using just your smartphone or tablet. Our products are backed by more than 20 years of innovative research in digital biomarkers, augmented reality (AR), and artificial intelligence (AI). Altoida received FDA Breakthrough Device Designation in July 2021. Our first device is a Computerized Cognitive Assessment Aid that is classified as Class II, 510(k) exempt.

Total Funding Amount:

$24.7M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Washington, District of Columbia, United States

Founded Date:

2016-01-01

Contact Email:

hello(AT)altoida.com

Founders:

Adrian Locher, Fabian Wahle, Ioannis Tarnanas, Maximilian Bügler, Richard Fischer